vs
Side-by-side financial comparison of Laser Photonics Corp (LASE) and Wellgistics Health, Inc. (WGRX). Click either name above to swap in a different company.
Wellgistics Health, Inc. is the larger business by last-quarter revenue ($1.7M vs $919.3K, roughly 1.8× Laser Photonics Corp). Laser Photonics Corp runs the higher net margin — -506.4% vs -1667.2%, a 1160.8% gap on every dollar of revenue.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
Wellgistics Health, Inc. is a U.S.-headquartered healthcare services firm focused on the distribution of prescription pharmaceuticals, over-the-counter medications, and medical supplies. Its key customer segments include retail pharmacies, long-term care facilities, and independent healthcare providers across the domestic market.
LASE vs WGRX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $919.3K | $1.7M |
| Net Profit | $-4.7M | $-27.9M |
| Gross Margin | -20.1% | -470.2% |
| Operating Margin | -350.0% | -1517.5% |
| Net Margin | -506.4% | -1667.2% |
| Revenue YoY | 28.3% | — |
| Net Profit YoY | -186.5% | — |
| EPS (diluted) | $-0.27 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.7M | ||
| Q3 25 | $919.3K | $3.0M | ||
| Q2 25 | $2.6M | $7.8M | ||
| Q1 25 | $2.3M | $10.9M | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $716.7K | — | ||
| Q2 24 | $623.4K | — | ||
| Q1 24 | $743.0K | — |
| Q4 25 | — | $-27.9M | ||
| Q3 25 | $-4.7M | $-34.3M | ||
| Q2 25 | $-1.8M | $-6.7M | ||
| Q1 25 | $-1.7M | $-32.4M | ||
| Q4 24 | $586.4K | — | ||
| Q3 24 | $-1.6M | — | ||
| Q2 24 | $-934.3K | — | ||
| Q1 24 | $-545.7K | — |
| Q4 25 | — | -470.2% | ||
| Q3 25 | -20.1% | 7.7% | ||
| Q2 25 | 53.5% | 6.5% | ||
| Q1 25 | 49.8% | 6.4% | ||
| Q4 24 | 13.3% | — | ||
| Q3 24 | 85.0% | — | ||
| Q2 24 | 50.6% | — | ||
| Q1 24 | 51.9% | — |
| Q4 25 | — | -1517.5% | ||
| Q3 25 | -350.0% | -1047.1% | ||
| Q2 25 | -37.0% | -70.6% | ||
| Q1 25 | -68.7% | -288.6% | ||
| Q4 24 | -255.1% | — | ||
| Q3 24 | -238.0% | — | ||
| Q2 24 | -149.4% | — | ||
| Q1 24 | -73.8% | — |
| Q4 25 | — | -1667.2% | ||
| Q3 25 | -506.4% | -1139.0% | ||
| Q2 25 | -68.3% | -85.6% | ||
| Q1 25 | -73.4% | -298.5% | ||
| Q4 24 | 45.7% | — | ||
| Q3 24 | -226.8% | — | ||
| Q2 24 | -149.9% | — | ||
| Q1 24 | -73.4% | — |
| Q4 25 | — | $-0.24 | ||
| Q3 25 | $-0.27 | $-0.46 | ||
| Q2 25 | $-0.12 | $-0.11 | ||
| Q1 25 | $-0.12 | $-0.62 | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $-0.13 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $42.6K |
| Total DebtLower is stronger | — | $23.5M |
| Stockholders' EquityBook value | $4.1M | $-12.4M |
| Total Assets | $17.5M | $30.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $42.6K | ||
| Q3 25 | $3.6M | $4.2M | ||
| Q2 25 | $78.5K | $419.9K | ||
| Q1 25 | $179.1K | $2.5M | ||
| Q4 24 | $533.9K | — | ||
| Q3 24 | $2.1M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | — | $23.5M | ||
| Q3 25 | — | $24.8M | ||
| Q2 25 | — | $23.3M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-12.4M | ||
| Q3 25 | $4.1M | $6.8M | ||
| Q2 25 | $4.3M | $905.3K | ||
| Q1 25 | $6.8M | $4.5M | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | $9.7M | — | ||
| Q2 24 | $10.3M | — | ||
| Q1 24 | $12.4M | — |
| Q4 25 | — | $30.5M | ||
| Q3 25 | $17.5M | $52.8M | ||
| Q2 25 | $14.9M | $54.2M | ||
| Q1 25 | $16.0M | $58.1M | ||
| Q4 24 | $17.2M | — | ||
| Q3 24 | $10.6M | — | ||
| Q2 24 | $11.1M | — | ||
| Q1 24 | $13.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.66× | ||
| Q2 25 | — | 25.72× | ||
| Q1 25 | — | 5.39× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $763.1K | $-6.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-6.3M | ||
| Q3 25 | $763.1K | $-1.1M | ||
| Q2 25 | $-1.0M | $-2.1M | ||
| Q1 25 | $-1.2M | $-1.3M | ||
| Q4 24 | $-6.5M | — | ||
| Q3 24 | $632.7K | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-866.3K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $589.6K | — | ||
| Q2 24 | $-2.4M | — | ||
| Q1 24 | $-1.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 82.3% | — | ||
| Q2 24 | -388.0% | — | ||
| Q1 24 | -136.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.0% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 20.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -11.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LASE
Segment breakdown not available.
WGRX
| Products | $1.0M | 61% |
| Other | $656.6K | 39% |
